Latest Content

K8 is a member of a new class of inflammasome-inhibiting drugs called kamuvudines.

Isocyclosporin is a dual inhibitor of transient receptor potential cation channel, mucolipin subfamily, member 2 (TRPML2), and calcineurin.

Aldeyra met with the FDA on December 12, 2025, in which the FDA requested the company submit the CSR from the reproxalap dry eye disease field trial to the NDA.

Nancy Gries, export sales manager at Logoproject Eyewear, stated that a private label eyewear brand can keep a practice up to date with trends.

Optometrists have their eyes set on ocular surface disease treatment and contact lens technology advancement.

The grading scales were compiled with the goals of achieving conciseness and the ability to provide clear drug-dose-modification recommendations compared with the previous ocular CTCAE scale.

Knowing the legal limits of treating family members can ease feelings of obligation.

Nancy Gries, export sales manager at Logoproject Eyewear, discusses the company's process for creating a private label eyewear brand, from logo design to final product.

Xelafaslatide is a small-molecule Fas inhibitor designed to protect key retinal cells, including photoreceptors, from cell death.

The eye care providers authored an opinion article that has been published in "The Ocular Surface."

Diana Canto-Sims, OD, and Nancy Gries, export sales manager at Logoproject Eyewear, discuss profit margins in creating a private label eyewear brand.

ODs are in a prime position to identify exploited victims.

VR technology captures not only visual fields but a full “stack” of pretest results.